SCHEMBL2201766

SCHEMBL2201766

O=C(c1ccc(C(=O)C(F)(F)F)s1)N1C[C@@H]2C[C@H]1CN2c1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.41
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
AKR1C3 P42330 1/20 0.40
HDAC6 Q9UBN7 9/20 0.39
HDAC1 Q13547 9/20 0.39
HDAC4 P56524 6/20 0.39
HDAC3 O15379 4/20 0.39
CYP2C9 P11712 3/20 0.37
RORC P51449 2/20 0.35
MTOR P42345 1/20 0.34
MEN1 O00255 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4775033 1.00 FAAH (0.41) FAAHDRD2DRD4DRD3AKR1C3
SCHEMBL17707649 0.91 AKR1C3 (0.50) FAAHDRD2DRD4DRD3AKR1C3
Trifluoroacetic Acid SCHEMBL2202123 0.88 AKR1C3 (0.47) DRD2DRD4DRD3AKR1C3HDAC6
SCHEMBL17707587 0.87 HDAC6 (0.48) FAAHAKR1C3HDAC6HDAC1HDAC4
Trifluoroacetic Acid SCHEMBL17707673 0.84 HDAC6 (0.46) FAAHAKR1C3HDAC6HDAC1HDAC4
Trifluoroacetic Acid SCHEMBL4776699 0.84 HDAC6 (0.46) FAAHAKR1C3HDAC6HDAC1HDAC4
SCHEMBL17707612 0.83 SLC6A7 (0.44) FAAHAKR1C3HDAC6HDAC1HDAC4
SCHEMBL17707557 0.80 HDAC6 (0.45) HDAC6HDAC1HDAC4HDAC3CYP2C9
SCHEMBL17707667 0.79 HDAC6 (0.47) AKR1C3HDAC6HDAC1HDAC4HDAC3
Trifluoroacetic Acid SCHEMBL2204116 0.77 HDAC6 (0.43) HDAC6HDAC1HDAC4HDAC3CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1926721-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-05-04 EP claimed
EP-1926721-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-05-04 EP disclosed
US-7977374-B2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-07-12 US disclosed
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors MSD ITALIA S.R.L. (IT) 2009-06-18 US disclosed
EP-1926721-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2008-06-04 EP disclosed
WO-2007029035-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors HDAC1, HDAC2, HDAC11 FAAH 1254/4885DRD2 2793/4885DRD4 2038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.